Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johnathan C Lai

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Annals of Biomedical Engineering|June 8, 2002
Single-cell measurements of polyamidoamine dendrimer bindingJohnathan C Lai, Calin Yuan, James L Thomas
American Journal of Physiology. Cell Physiology|December 1, 2006
Phosphorothioate oligonucleotides reduce mitochondrial outer membrane permeability to ADPWenzhi Tan, Johnathan C Lai, Paul Miller, et al.
Annals of the New York Academy of Sciences|January 6, 2006
Induction of apoptosis by G3139 in melanoma cellsLuba Benimetskaya, Johnathan C Lai, Anastasia Khvorova, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 2, 2006
A pharmacologic target of G3139 in melanoma cells may be the mitochondrial VDACJohnathan C Lai, Wenzhi Tan, Luba Benimetskaya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2004
Antisense RNA down-regulation of bcl-2 expression in DU145 prostate cancer cells does not diminish the cytostatic effects of G3139 (Oblimersen)Anthony Raffo, Johnathan C Lai, C A Stein, et al.
Molecular Cancer Therapeutics|February 17, 2005
Phosphorothioate oligodeoxynucleotides and G3139 induce apoptosis in 518A2 melanoma cellsJohnathan C Lai, Luba Benimetskaya, Anastasia Khvorova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Relative Bcl-2 independence of drug-induced cytotoxicity and resistance in 518A2 melanoma cellsLuba Benimetskaya, Johnathan C Lai, Anastasia Khvorova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2004
Changes in gene expression induced by phosphorothioate oligodeoxynucleotides (including G3139) in PC3 prostate carcinoma cells are recapitulated at least in part by treatment with interferon-beta and -gammaLuba Benimetskaya, Timo Wittenberger, C A Stein, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 20, 2007
Comparison of d-g3139 and its enantiomer L-g3139 in melanoma cells demonstrates minimal in vitro but dramatic in vivo chiral dependencyJohnathan C Lai, Bob D Brown, Anatoliy M Voskresenskiy, et al.
Breast Cancer Research and Treatment|May 17, 2014
Novel genetic aberrations in breast phyllodes tumours: comparison between prognostically distinct groupsWai Jin Tan, Johnathan C Lai, Aye Aye Thike, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Annals of Biomedical Engineering|June 8, 2002
Single-cell measurements of polyamidoamine dendrimer bindingJohnathan C Lai, Calin Yuan, James L Thomas
American Journal of Physiology. Cell Physiology|December 1, 2006
Phosphorothioate oligonucleotides reduce mitochondrial outer membrane permeability to ADPWenzhi Tan, Johnathan C Lai, Paul Miller, et al.
Annals of the New York Academy of Sciences|January 6, 2006
Induction of apoptosis by G3139 in melanoma cellsLuba Benimetskaya, Johnathan C Lai, Anastasia Khvorova, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 2, 2006
A pharmacologic target of G3139 in melanoma cells may be the mitochondrial VDACJohnathan C Lai, Wenzhi Tan, Luba Benimetskaya, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2004
Antisense RNA down-regulation of bcl-2 expression in DU145 prostate cancer cells does not diminish the cytostatic effects of G3139 (Oblimersen)Anthony Raffo, Johnathan C Lai, C A Stein, et al.
Molecular Cancer Therapeutics|February 17, 2005
Phosphorothioate oligodeoxynucleotides and G3139 induce apoptosis in 518A2 melanoma cellsJohnathan C Lai, Luba Benimetskaya, Anastasia Khvorova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Relative Bcl-2 independence of drug-induced cytotoxicity and resistance in 518A2 melanoma cellsLuba Benimetskaya, Johnathan C Lai, Anastasia Khvorova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2004
Changes in gene expression induced by phosphorothioate oligodeoxynucleotides (including G3139) in PC3 prostate carcinoma cells are recapitulated at least in part by treatment with interferon-beta and -gammaLuba Benimetskaya, Timo Wittenberger, C A Stein, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 20, 2007
Comparison of d-g3139 and its enantiomer L-g3139 in melanoma cells demonstrates minimal in vitro but dramatic in vivo chiral dependencyJohnathan C Lai, Bob D Brown, Anatoliy M Voskresenskiy, et al.
Breast Cancer Research and Treatment|May 17, 2014
Novel genetic aberrations in breast phyllodes tumours: comparison between prognostically distinct groupsWai Jin Tan, Johnathan C Lai, Aye Aye Thike, et al.
Pageof 1